Sandbox: RAB: Difference between revisions

Jump to navigation Jump to search
 
(30 intermediate revisions by the same user not shown)
Line 2: Line 2:
==Rough sheet for Rinky==
==Rough sheet for Rinky==


<br /><br />


Selection of therapeutic options through guideline-recommended treatment of asthma exacerbations has not been affected by what we currently know about COVID-19.


Systemic corticosteroids should be used to treat an asthma exacerbation per national asthma guidelines and current standards of care, even if it is caused by COVID-19. Short-term use of systemic corticosteroids to treat asthma exacerbations should be continued. There is currently no evidence to suggest that short-term use of systemic corticosteroids to treat asthma exacerbations increases the risk of developing severe COVID-19, whereas there is an abundance of data to support use of systemic steroids for moderate or severe asthma exacerbations.
{| style="border: 2px solid #4479BA; align="left"
Patients with asthma but without symptoms or a diagnosis of COVID-19 should continue any required nebulizer for treatments, as recommended by national professional organizations.If healthcare providers need to be present during nebulizer use among patients who have either symptoms or a diagnosis of COVID-19, they should use recommended precautions when performing aerosol-generating procedures (AGPs).
! style="width: Phenotype Domains; background: #4479BA;" | {{fontcolor|#FFF|Phenotype Domains}}
If clinicians are concerned that an asthma exacerbation is related to an underlying infection with COVID-19, clinicians can access laboratory testing for COVID-19 through a network of state and local public health laboratories across the country.
! style="width: Clinical Features; background: #4479BA;" | {{fontcolor|#FFF|Clinical Features}}
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Urinary
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Lower urinary tract symptoms that creates discomfort or High post-micturation residual volume
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Psychological
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Patient with depression or severe anxiety thinking the worst will happen to them 
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Organ-specific
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Tenderness in Prostate,Presence of blood in ejaculation,Leukocytes in prostatic fluid or post-massage urine
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Infectious
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Infection with gram negative bacilli or Enterococii localized to prostate or presence of Ureaplasma in urine
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Systemic
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Pain anywhere else in the body except abdomen or pelvis or having a diagnosis of fibromyalgia,chronic fatigue or irritable bowel syndrome
|-
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Tenderness
| style="padding: 0 5px; background: #F5F5F5; text-align: left;" | Presence of palpable musvle spams in abodomen or pelvic floor
|-
|}
{{clear}}
 
 
 
 
 
 


If patients with asthma who have symptoms or a diagnosis of COVID-19 need to use nebulizer at home,it is recommended by national professional organizations that they should use the nebulizer in a location that minimizes and preferably avoids exposure to any other members of the household, and preferably a location where air is not recirculated into the home (like a porch, patio, or garage) .Limiting the number of people in the room or location where the nebulizer is used is also recommended. Nebulizers should be used and cleaned according to the manufacturer’s instructions.
If nebulizer use in a healthcare setting is necessary for patients who have either symptoms or a diagnosis of COVID-19, they must use recommended precautions when performing aerosol-generating procedures (AGPs).




Wastewater workers should use standard practices including basic hygiene precautions and wear the recommended PPE( Personal Protective Equipment) like goggles,protective face mask or splash-proof face shield,liquid-repellent coveralls,waterproof gloves,rubber boots as prescribed for their current work tasks when handling untreated waste.Basic Hygiene precautions include:
*Washing hands with soap and water immediately after handling human waste or sewage.
*Avoid touching face, mouth, eyes, nose, or open sores and cuts while handling human waste or sewage.
*After handling human waste or sewage, wash hands with soap and water before eating or drinking.
*After handling human waste or sewage, wash hands with soap and water before and after using the toilet.
*Removing soiled work clothes before eating food and eating in designated areas away from human waste and sewage-handling activities.
*Not smoking or chewing tobacco or gum while handling human waste or sewage.
*Keeping open sores, cuts, and wounds covered with clean, dry bandages.
*Gently flushing eyes with safe water if human waste or sewage contacts eyes.
*Using waterproof gloves to prevent cuts and contact with human waste or sewage.
*Wearing rubber boots at the worksite and during transport of human waste or sewage.
*Removing rubber boots and work clothes before leaving worksite.
*Cleaning contaminated work clothing daily with 0.05% chlorine solution (1-part household bleach to 100-parts water).




There are no additional precautions for HCP. Some HCP may choose to implement extra measures when arriving home from providing healthcare, such as removing any clothing worn during delivery of healthcare, taking off shoes, washing clothing, and immediately showering. However, these are optional personal practices because there is insufficient evidence on whether they are effective.People at higher risk of severe illness from COVID-19 should take the general precautions recommended for them which includes:
{{familytree/start |summary=Sample 9}}{{familytree/start |summary=PE diagnosis Algorithm.}}
Washing hands often, taking everyday precautions to keep space between them and others (stay 6 feet away, which is about two arm lengths),staying away from people who are sick,cleaning and disinfecting frequently touched services.
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | A01 | | |A01= '''Table'''<br>
<table class="wikitable">
<tr class="v-firstrow"><th>'''Phenotype Domains '''</th><th>'''Clinical presentation'''</th></tr>
<tr><td>'''Urinary'''</td><td>Lower urinary tract symptoms that creates discomfort or High post-micturation residual volume</td></tr>
<tr><td>'''Psychological'''</td><td>Patient with depression or severe anxiety thinking the worst will happen to them</td></tr>
<tr><td>'''Organ-specific'''</td><td>Tend\erness in Prostate,Presence of blood in ejaculation,Leukocytes in prostatic fluid or post-massage urine</td></tr>
<tr><td>'''Infectious'''</td><td>Infection with gram negative bacilli or Enterococii localized to prostate or presence of Ureaplasma in urine</td></tr>
<tr><td>'''Systemic'''</td><td>Pain anywhere else in the body except abdomen or pelvis or having a diagnosis of fibromyalgia,chronic fatigue or irritable bowel syndrome</td></tr>
<tr><td>'''Tenderness'''</td><td>Presence of palpable musvle spams in abodomen or pelvic floor</td></tr>
</table>}}
{{familytree/end}}




There is no evidence to suggest that employees of wastewater plants need any additional protections in relation to COVID-19.
{{familytree/start}}
{{family tree| | | | | | | B01 | | | | B01=<div style="float: left; text-align: left;width: 28em; padding:1em;"> '''UPOINT domains''' <div class="mw-collapsible mw-collapsed"><br>
{{familytree/start |summary=Sample 9}}{{familytree/start |summary=PE diagnosis Algorithm.}}
{{familytree/start}}
{{familytree | | | | | | | | | | | | | | A01 | | |A01= '''Table'''
<table class="wikitable">
<tr class="v-firstrow"><th>'''Phenotype Domains '''</th><th>'''Clinical presentation'''</th></tr>
<tr><td>'''Urinary'''</td><td>Lower urinary tract symptoms that creates discomfort or High post-micturation residual volume</td></tr>
<tr><td>'''Psychological'''</td><td>Patient with depression or severe anxiety thinking the worst will happen to them</td></tr>
<tr><td>'''Organ-specific'''</td><td>Tend\erness in Prostate,Presence of blood in ejaculation,Leukocytes in prostatic fluid or post-massage urine</td></tr>
<tr><td>'''Infectious'''</td><td>Infection with gram negative bacilli or Enterococii localized to prostate or presence of Ureaplasma in urine</td></tr>
<tr><td>'''Systemic'''</td><td>Pain anywhere else in the body except abdomen or pelvis or having a diagnosis of fibromyalgia,chronic fatigue or irritable bowel syndrome</td></tr>
<tr><td>'''Tenderness'''</td><td>Presence of palpable musvle spams in abodomen or pelvic floor</td></tr>
</table>}}
</div> }}


==Complications in Central Nervous System==
==Complications in Central Nervous System==
Line 225: Line 260:


-------
-------
here is how we use reference <ref name="pmid32379918">{{cite journal| author=Connell NT, Battinelli EM, Connors JM| title=Coagulopathy of COVID-19 and antiphospholipid antibodies. | journal=J Thromb Haemost | year= 2020 | volume=  | issue=  | pages=  | pmid=32379918 | doi=10.1111/jth.14893 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=32379918  }} </ref>
here is how we use reference  




Line 356: Line 391:
#this is how numbers are added
#this is how numbers are added
----
----
reference<ref name="pmid19032997">{{cite journal| author=Gibson CM, Pride YB, Frederick PD, Pollack CV, Canto JG, Tiefenbrunn AJ | display-authors=etal| title=Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. | journal=Am Heart J | year= 2008 | volume= 156 | issue= 6 | pages= 1035-44 | pmid=19032997 | doi=10.1016/j.ahj.2008.07.029 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19032997  }} </ref>
reference
<references />

Latest revision as of 14:20, 14 August 2020

Rough sheet for Rinky

Phenotype Domains Clinical Features
Urinary Lower urinary tract symptoms that creates discomfort or High post-micturation residual volume
Psychological Patient with depression or severe anxiety thinking the worst will happen to them
Organ-specific Tenderness in Prostate,Presence of blood in ejaculation,Leukocytes in prostatic fluid or post-massage urine
Infectious Infection with gram negative bacilli or Enterococii localized to prostate or presence of Ureaplasma in urine
Systemic Pain anywhere else in the body except abdomen or pelvis or having a diagnosis of fibromyalgia,chronic fatigue or irritable bowel syndrome
Tenderness Presence of palpable musvle spams in abodomen or pelvic floor






 
 
 
 
 
 
 
 
 
 
 
 
 
Table
Phenotype Domains Clinical presentation
UrinaryLower urinary tract symptoms that creates discomfort or High post-micturation residual volume
PsychologicalPatient with depression or severe anxiety thinking the worst will happen to them
Organ-specificTend\erness in Prostate,Presence of blood in ejaculation,Leukocytes in prostatic fluid or post-massage urine
InfectiousInfection with gram negative bacilli or Enterococii localized to prostate or presence of Ureaplasma in urine
SystemicPain anywhere else in the body except abdomen or pelvis or having a diagnosis of fibromyalgia,chronic fatigue or irritable bowel syndrome
TendernessPresence of palpable musvle spams in abodomen or pelvic floor
 
 


 
 
 
 
 
 
UPOINT domains

Complications in Central Nervous System

  1. Cerebrovascular Accident
  2. Hemorrhagic
  3. Ischaemic
  4. Acute Encephalitis
  5. Viral Meningitis
  6. Epileptic Seizures
  7. Encephalopathy
  8. Headache

Complications in Peripheral Nervous system

  1. Guillain-Barre syndrome
  2. Anosmia
  3. Acute Myelitis
  4. Miller Fischer Sydrome
  5. Polyneuritis Cranialis

Ego defenses

Immature Defenses

  • Acting Out
    Expressing unacceptable feelings and thoughts through actions
  • Denial
    Avoiding the awreness of painful reality
  • Displacemnet
    Transferring avoided ideas to neutral persons
  • Idealization
    Expressing extreme positive thoughts of self and others while ignoring negative thoughts
  • Identification
    Modeling behaviour after one person who is more powerful.
These ego defenses are unconsious or conscious

DEFENSES
DEFENSES
Defenses

Return to top

Mature Defenses

  • Sublimitaion
    Replacing an unacceptable wish with a course of action that is similar to the wish but does not conflict with one's value system.
  • Altruism
    alleviating negative feelings via unsolicited generosity.
  • Suppression
    Intentionally withholding an idea or feeling.

16,Saturday,11,2024




 
 
 
 
 
 
 
 
 
 
 
 
 
Table
Phenotype Domains Clinical presentation
UrinaryLower urinary tract symptoms that creates discomfort or High post-micturation residual volume
PsychologicalPatient with depression or severe anxiety thinking the worst will happen to them
Organ-specificTend\erness in Prostate,Presence of blood in ejaculation,Leukocytes in prostatic fluid or post-massage urine
InfectiousInfection with gram negative bacilli or Enterococii localized to prostate or presence of Ureaplasma in urine
SystemicPain anywhere else in the body except abdomen or pelvis or having a diagnosis of fibromyalgia,chronic fatigue or irritable bowel syndrome
TendernessPresence of palpable musvle spams in abodomen or pelvic floor
 
 
 
 
 
Increased behaviour Decreased behaviour
Add stimulus (+)ve reinformation (+)ve punishment
Remove stimulus (-)ve reinformation


(-)ve punishment



Tumor nomenclature

Carcinoma implies epithelial origin,whereas sarcoma denotes mesenchymal origin. Both terms imply malignancy. terms for non-neoplastic malformations include hamartoma(disorganized overgrowth of tissues in their native location, eg, Peutz- Jeghes polyps) and choriostoma9 normal tissue in foreign location, eg, gastric tissue located in distal ileum in Meckel Diverticulum).

  • Benign tumor may show well demarcation, well diffreentiation, low mitotic activity, no necrosis, no metastasis.
  • Malignant tumor shows poor demarcation, poor mitotic activity, erratic growth, local invasion, metastasis, reduced apoptosis. Upregulation of telomerase prevents chromosome shortening and cell death.
CELL TYPE Benign
Malignant
Epithelium Adenoma,papilloma Adenocarcinoma, papillary carcinoma
Messenchmye
Blood cells lekaemia,Lymphoma
Blood vessels Hemangioma Angiosarcoma
Smooth muscle Leiomyoma Leiomyosarcoma
Striated muscle Rhabdomyoma Rhabdomyosarcoma
Connective tissue Fibroma Fibrosarcoma
Bone Osteoma Osteosarcoma
Fat Lipoma Liposarcoma
Melanocyte Nevus/Mole Melanoma



here is how we use reference




TYPE DEFINITION EXAMPLES STRATEGY TO REDUCE BIAS


Selection Bias Error in assigning subjects to a study group resulting in an unreprestative sample.Most commomnly a sampling bias
Berkson Bias
study population selected from hospital is less healthy than general population
Healthy worker effect
study population is healthier than the general population
Non-response bias
participating subjects differ from nonrespondents in meaningful ways.
randomization
Recall Bias Awareness of disorder alters recall by subjects; common in retrospective studies patients with disease recall exposure after learning of similar cases Decrease time from exposure to followup


Measurement Bias Information is gathered in a systemically distorted manner. Association between HPV and cervical cancer not observed when using non-standarized classifications/ Use objective, standardized, and previously tested methods of data collection that are planned ahead of time
Procedure Bias subjects in different groups are not treated the same patients in treatment group spend more time in highly specialized hospital units Blinding and use of placebo
Observer- expectancy Bias Researche's belief in the efficacy of a treatment changes the outcome of that treatment If observer expects treatment group to show signs of recovery, then he is more likely to document positive outcomes. Blinding



Heart Failure

Clinical syndrome of cardiac pump dysfunction-->congestion and low perfusion. Symptoms inlude dyspnea,orthopnea,fatigue; signs include rale,jugular venous distention(JVD),pitting edema.


Systolic Dysfunction
reduced EF,increased EDV;decreased contracility often secondary to ischaemia/MI or dialted cardiomyopathy
Diastolic Dysfunction
preserved EF, normal EDV;compliance often secondary to myocardial hypertrophy.



Caused BY Skin Preload CO Afterload Treatment
Hypovolumic hemorrhage,dehydration,burns Cold,clammy reduced reduced increased IV fluids
Cardiogenic Acute MI,HF Cold,clammy increased reduced Increased Inotropes, diuresis
Distributive Sepsis, anaphylaxis warm,dry reduced increased reduced IV fluids,pressors
  • this is how we add bullets
    • this is how layers
  1. this is how numbers are added

reference